What is the role of eculizumab in the treatment of myasthenia gravis (MG)?

Updated: Aug 27, 2018
  • Author: Abbas A Jowkar, MBBS; Chief Editor: Nicholas Lorenzo, MD, CPE, MHCM, FAAPL  more...
  • Print

Emerging novel therapies targeting immunopathogenesis of MG

  • Eculizumab is a humanized monoclonal IgG antibody against terminal complement activity (C5b-9) preventing its depositing at the NMJ in adult patients with anti-AchR+ve gMG.

Did this answer your question?
Additional feedback? (Optional)
Thank you for your feedback!